We use cookies for a better user experience. Read our Privacy Policy

I Agree

Cell Culture Market

Cell Culture Market (Product: Instruments, Media, Sera, and Reagents; and End-user: Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Cell Culture Market Outlook 2031

  • The global market was valued at US$ 10.5 Bn in 2020
  • It is estimated to expand at a CAGR of 9% from 2021 to 2031
  • The global cell culture industry is expected to reach the value of US$ 27.6 Bn by the end of 2031

Analysts’ Viewpoint on Market Scenario

In order to increase the availability of immune-boosting medicines, stakeholders in the global market for cell culture should enter into mergers & acquisitions to make optimum use of financial budgets amid the COVID-19 pandemic. Since FBS is linked with potential risk of disease transmission due to prions, bacteria, or viruses, researchers should adopt alternatives to FBS such as human AB serum and thrombin-activated platelet rich plasma to increase the availability of advanced therapy medicinal products. Moreover, favorable reimbursement programs for individuals in Africa and the Middle East are contributing to the expansion of the market for cell culture. Increase in demand for cost-effective and highly efficient cell culture products such as bioreactors, media, reagents, and sera for the production of high-yield cell lines has led to a rise in the number of new product launches.

Leading-edge Cell Culture Products in Demand for Treatment of Chronic Diseases

Advancements in the cell culture market, in terms of innovations in instruments, media, reagents, and sera are benefitting stakeholders in academic institutes, research centers, biotech companies, and pharmaceutical organizations. Launch of advanced cell culture products and demand for novel therapeutics such as biosimilar are expected to boost the growth of the global market throughout the assessment tenure.

Since cell culture is primarily associated with the diagnosis of infections, testing of new drugs, and other R&D activities, the market is projected to expand at a robust CAGR during the forecast period. The high prevalence of chronic diseases such as cancer, diabetes, renal diseases, and cardiovascular diseases is fueling the demand for cell culture activities to increase the availability of treatment options and therapeutic agents.

Request a sample to get extensive insights into the Cell Culture Market

R&D Investments in Immune-boosting Medicines Hold Potentials for Minimizing COVID-19 Risks

The emergence of a new COVID-19 wave in India, China, and the U.K. has brought vaccine companies, biotech companies, and healthcare companies under great scrutiny. In order to win the faith of common individuals and high-risk patients with existing comorbidities, companies in the cell culture market should invest in R&D to innovate and introduce life-saving therapeutics in the market.

Healthcare companies are making use of government stimulus packages and financial schemes provided by the BFSI sector to support research activities in vaccine development and immune-boosting medicines. They should maintain robust supply chains for instruments, sera, media, and reagents to support research activities in academic institutes and biotech companies.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Can Alternatives to Fetal Bovine Serum Transform Cell Culture Market?

Fetal bovine serum (FBS) is commonly used as a serum-supplement for the in vitro cell culture of eukaryotic cells. However, ethical issues pertaining to FBS is affecting research activities in the global market for cell culture, since fetal bovine serum is derived from the blood drawn from a bovine fetus via a closed system of collection at the slaughterhouse. Hence, researchers are now resorting to alternatives for FBS such as human AB serum and thrombin-activated platelet-rich plasma to excel in cell culture activities.

Alternatives to FBS are becoming necessary, as, in the past years, advanced therapy medicinal products (ATMP) and cell therapy have become increasingly important in terms of clinical use.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Cell Culture Market

Burgeoning Demand for Biosimilars and Biologic Therapeutics Fueling Market Growth

The high demand for biosimilars and other biologic therapeutics is acting as a key driver for the cell culture industry. This is evident since cell culture helps to increase efficiency & productivity and reduce the cost of manufacture for biologic therapeutics. Healthcare companies are investing in clinical trials to increase the availability of approved biosimilar products. Such advancements are playing an instrumental role in the development of treatment alternatives for chronic diseases in developed as well as developing countries.

Biotech companies are catering to the increase in demand for efficient and cost-effective biosimilars and biologic therapeutics.

Africa and Middle East Offer Lucrative Growth Opportunities to Companies

Apart from Asia Pacific, companies in the cell culture market are witnessing an increase in the per capita income of individuals in countries of Africa and the Middle East. This improvement in the per capita income can be attributed to rising employment and business opportunities for citizens within the country, and also in countries outside of Africa and the Middle East. Thus, investments toward the development of the healthcare infrastructure in Africa and the Middle East are benefitting stakeholders in the market for cell culture.

In many instances, it has been observed that despite having the income for medical treatments, lack of basic healthcare facilities in rural and remote areas of Africa and the Middle East is affecting patient outcomes. In order to improve patient quality of life, companies should set up biotech companies, research institutes, and academic centers in these regions. These developments are necessary due to high prevalence of rare diseases among the people of Africa and the Middle East.

Cell Culture Industry: Overview

  • Cell culture is used in a range of applications such as development of model systems for research, analysis of cellular structures & their mechanisms, drug discovery for treatment of diseases such as Alzheimer’s, stem cell research, drug evaluation, genetic engineering, and production of biologics such as antibodies, vaccines, and proteins
  • Applications such as stem cell research have significant market potential. Stem cell culture assists in standardization of drug production and enables production of various cell lines and related products.
  • Traditional pharmaceutical therapeutics help in treating only disease symptoms, whereas stem cell therapies assist in treating the cause of the disease. Hence, further research in the field of stem cell culture for development of drugs presents an opportunity in the market.

Rise in Demand for Cell Culture: Major Driver

  • Manufacturing of biopharmaceuticals involves use of cell culture systems as a unique method of product development as such products are difficult to be produced by conventional pharmaceutical development processes
  • Research & development in the field of biopharmaceuticals that concentrates on discovery of new therapeutics for rare diseases and new mechanisms of drug actions has increased the scope for cell culture in biologics
  • Rise in outsourcing activities and expansion of biopharmaceutical manufacturers are expected to drive the market during the forecast period

Instruments Segment to Dominate Cell Culture Market

  • The global cell culture market has been segmented based on product, end-user, and region
  • In terms of product, the global market has been classified into instruments, media, sera, and reagents. The instruments segment has been split into cell culture vessels (bioreactors), carbon dioxide incubators, biosafety cabinets, cryogenic tanks, and others. The media segment has been segregated into chemically defined, classical media, protein-free media, Lysogeny media, serum-free media, and specialty media. The sera segment has been bifurcated into fetal bovine serum and others. The reagents segment has been split into albumin, amino acid, attachment factors, growth factors & cytokines, protease inhibitor, thrombin, and others.
  • Increase in trend toward the use of animal-derived component-free media and adoption of chemically defined and specialty media is projected to drive the global market in the near future
  • Moreover, automation of cell culture systems demand more sophisticated instruments and equipment. This is anticipated to boost the growth of the instruments segment.

Asia Pacific to Dominate Cell Culture Business

  • In terms of region, the global cell culture market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • Asia Pacific is expected to dominate the global market during the forecast period. This can be attributed to the adoption of new technologies such as next-generation sequencing, higher awareness, increase in healthcare spending in national budgets, early availability of advanced technologies, and higher penetration of research activities across the region.
  • Rise in outsourcing activities and expansion of biopharmaceutical manufacturers are projected to drive the market in Asia Pacific during the forecast period. Moreover, low cost of manufacturing in China and India has led to rise in the production facilities, attracting pharmaceutical & biotechnological companies to the region.

Major Players

  • Key players operating in the global cell culture market include
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • Eppendorf AG
    • GE Healthcare
    • Corning Incorporated
    • Becton
    • Dickinson and Company
    • Merck KGaA
    • Lonza
    • VWR International, LLC
    • PromoCell GmbH
  • Each of these players has been profiled in the cell culture market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

Cell Culture Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 10.5 Bn

Market Forecast Value in 2031

US$ 27.6 Bn

Growth Rate (CAGR)

9%

Forecast Period

2021–2031

Quantitative Units

US$ Bn for Value

Market Analysis

It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview.

Format

Electronic (PDF)

Market Segmentation

  • Product
    • Instruments
      • Cell Culture Vessels (Bioreactor)
      • Carbon dioxide Incubators
      • Biosafety Cabinets
      • Cryogenic Tanks
      • Others
    • Media
      • Chemically Defined
      • Classical Media
      • Lysogeny Broth
      • Serum Free
      • Protein Free
      • Specialty Media
    • Sera
      • Fetal Bovine Serum (FBS)
      • Others
    • Reagents
      • Growth Factors & Cytokines
      • Albumin
      • Protease inhibitor
      • Thrombin
      • Attachment Factors
      • Amino Acids
  • End-user
    • Biotechnology & Pharmaceutical & Companies
    • Academics & Research Institutes
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Brazil
  • Mexico
  • Rest of Latin America
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Companies Profiled

  • Sartorius AG
  • Thermo Fisher Scientific, Inc.
  • Eppendorf AG
  • GE Healthcare
  • Corning Incorporated
  • Becton, Dickinson and Company
  • Merck KGaA
  • Lonza
  • VWR International, LLC.
  • PromoCell GmbH

Customization Scope

Available upon request

Pricing

Available upon request

Cell Culture Market – Segmentation

TMR’s study on the global market for cell culture includes information divided into three segments: product, end-user, and region. Changing industry trends and other market dynamics associated with these segments of the global market are discussed in detail.

Product
  • Instruments
    • Cell Culture Vessels (Bioreactor)
    • Carbon Dioxide Incubators
    • Biosafety Cabinets
    • Cryogenic Tanks
    • Others
  • Media
    • Chemically Defined
    • Classical Media
    • Lysogeny Broth
    • Serum Free
    • Protein Free
    • Specialty Media
  • Sera
    • Fetal Bovine Serum (FBS)
    • Others
  • Reagents
    • Growth Factors & Cytokines
    • Albumin
    • Protease inhibitor
    • Thrombin
    • Attachment Factors
    • Amino Acids
End-user
  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutes
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Cell Culture Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of cell culture market?

The global market for Cell culture is expected to reach the value of US$ 30 billion by the end of 2028

What is the anticipated CAGR of the market for cell culture in the forecast period?

The global market for cell culture is anticipated to expand at a CAGR of 6.4% from 2021 to 2028

What are the key driving factors for the growth of the cell culture business?

The market is driven by a rise in demand for biopharmaceuticals, an increase in product development by players, and the rapid development of novel vaccines

Which is the rising prominent segment in the global market for cell culture?

The instruments segment dominated the global market in 2020 and the trend is projected to continue during the forecast period

Who are the key players in the global cell culture industry?

Top key players in global market are Thermo Fisher Scientific, Inc., Merck KGaA, GE Healthcare, Lonza Group, Sartorius AG, Becton, Dickinson and Company, Corning, Inc., Eppendorf AG, VWR International, PromoCell GmbH, among others

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cell Culture Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Cell Culture Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Top 3 players operating in the market space

    5.2. Key Mergers & Acquisitions

    5.3. Technological Advancements

    5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Cell Culture Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value & Volume Forecast, by Product Type, 2017–2031

        6.3.1. Instruments

            6.3.1.1. Cell Culture Vessels (bioreactor)

            6.3.1.2. Carbon Dioxide Incubators

            6.3.1.3. Biosafety Cabinets

            6.3.1.4. Cryogenic Tanks

            6.3.1.5. Others

        6.3.2. Media Type

            6.3.2.1. Chemically-defined

            6.3.2.2. Classical Media

            6.3.2.3. Lysogeny Broth (LB)

            6.3.2.4. Protein Free

            6.3.2.5. Serum Free

            6.3.2.6. Specialty Media

        6.3.3. Sera

            6.3.3.1. Fetal Bovine

            6.3.3.2. Newborn Calf

            6.3.3.3. Others

        6.3.4. Reagents

            6.3.4.1. Albumin

            6.3.4.2. Amino Acids

            6.3.4.3. Attached Factors

            6.3.4.4. Growth Factors & Cytokines

            6.3.4.5. Protease Inhibitors

            6.3.4.6. Thrombin

            6.3.4.7. Others

    6.4. Market Attractiveness Analysis, by Product Type

7. Global Cell Culture Market Analysis and Forecast, by End-user

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value & Volume Forecast, by End-user, 2017–2031

        7.3.1. Biotechnology & Pharmaceutical Companies

        7.3.2. Academic & Research Institutes

        7.3.3. Others

    7.4. Market Attractiveness Analysis, by End-user

8. Global Cell Culture Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value & Volume Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness Analysis, by Region

9. North America Cell Culture Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value & Volume Forecast, by Product Type, 2017–2031

        9.2.1. Instruments

            9.2.1.1. Cell Culture Vessels (bioreactor)

            9.2.1.2. Carbon Dioxide Incubators

            9.2.1.3. Biosafety Cabinets

            9.2.1.4. Cryogenic Tanks

            9.2.1.5. Others

        9.2.2. Media Type

            9.2.2.1. Chemically-defined

            9.2.2.2. Classical Media

            9.2.2.3. Lysogeny Broth (LB)

            9.2.2.4. Protein Free

            9.2.2.5. Serum Free

            9.2.2.6. Specialty Media

        9.2.3. Sera

            9.2.3.1. Fetal Bovine

            9.2.3.2. Newborn Calf

            9.2.3.3. Others

        9.2.4. Reagents

            9.2.4.1. Albumin

            9.2.4.2. Amino Acids

            9.2.4.3. Attached Factors

            9.2.4.4. Growth Factors & Cytokines

            9.2.4.5. Protease Inhibitors

            9.2.4.6. Thrombin

            9.2.4.7. Others

    9.3. Market Value & Volume Forecast, by End-user, 2017–2031

        9.3.1. Biotechnology & Pharmaceutical Companies

        9.3.2. Academic & Research Institutes

        9.3.3. Others

    9.4. Market Value & Volume Forecast, by Country, 2017–2031

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis

        9.5.1. By Product Type

        9.5.2. By End-user

        9.5.3. By Country

10. Europe Cell Culture Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value & Volume Forecast, by Product Type, 2017–2031

        10.2.1. Instruments

            10.2.1.1. Cell Culture Vessels (Bioreactor)

            10.2.1.2. Carbon Dioxide Incubators

            10.2.1.3. Biosafety Cabinets

            10.2.1.4. Cryogenic Tanks

            10.2.1.5. Others

        10.2.2. Media Type

            10.2.2.1. Chemically-defined

            10.2.2.2. Classical Media

            10.2.2.3. Lysogeny Broth (LB)

            10.2.2.4. Protein Free

            10.2.2.5. Serum Free

            10.2.2.6. Specialty Media

        10.2.3. Sera

            10.2.3.1. Fetal Bovine

            10.2.3.2. Newborn Calf

            10.2.3.3. Others

        10.2.4. Reagents

            10.2.4.1. Albumin

            10.2.4.2. Amino Acids

            10.2.4.3. Attached Factors

            10.2.4.4. Growth Factors & Cytokines

            10.2.4.5. Protease Inhibitors

            10.2.4.6. Thrombin

            10.2.4.7. Others

    10.3. Market Value & Volume Forecast, by End-user, 2017–2031

        10.3.1. Biotechnology & Pharmaceutical Companies

        10.3.2. Academic & Research Institutes

        10.3.3. Others

    10.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis

        10.5.1. By Product Type

        10.5.2. By End-user

        10.5.3. By Country/Sub-region

11. Asia Pacific Cell Culture Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value & Volume Forecast, by Product Type, 2017–2031

        11.2.1. Instruments

            11.2.1.1. Cell Culture Vessels (bioreactor)

            11.2.1.2. Carbon Dioxide Incubators

            11.2.1.3. Biosafety Cabinets

            11.2.1.4. Cryogenic Tanks

            11.2.1.5. Others

        11.2.2. Media Type

            11.2.2.1. Chemically-defined

            11.2.2.2. Classical Media

            11.2.2.3. Lysogeny Broth (LB)

            11.2.2.4. Protein Free

            11.2.2.5. Serum Free

            11.2.2.6. Specialty Media

        11.2.3. Sera

            11.2.3.1. Fetal Bovine

            11.2.3.2. Newborn Calf

            11.2.3.3. Others

            11.2.3.4. Total

        11.2.4. Reagents

            11.2.4.1. Albumin

            11.2.4.2. Amino Acids

            11.2.4.3. Attached Factors

            11.2.4.4. Growth Factors & Cytokines

            11.2.4.5. Protease Inhibitors

            11.2.4.6. Thrombin

            11.2.4.7. Others

    11.3. Market Value & Volume Forecast, by End-user, 2017–2031

        11.3.1. Biotechnology & Pharmaceutical Companies

        11.3.2. Academic & Research Institutes

        11.3.3. Others

    11.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis

        11.5.1. By Product Type

        11.5.2. By End-user

        11.5.3. By Country/Sub-region

12. Latin America Cell Culture Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value & Volume Forecast, by Product Type, 2017–2031

        12.2.1. Instruments

            12.2.1.1. Cell Culture Vessels (bioreactor)

            12.2.1.2. Carbon Dioxide Incubators

            12.2.1.3. Biosafety Cabinets

            12.2.1.4. Cryogenic Tanks

            12.2.1.5. Others

        12.2.2. Media Type

            12.2.2.1. Chemically-defined

            12.2.2.2. Classical Media

            12.2.2.3. Lysogeny Broth (LB)

            12.2.2.4. Protein Free

            12.2.2.5. Serum Free

            12.2.2.6. Specialty Media

        12.2.3. Sera

            12.2.3.1. Fetal Bovine

            12.2.3.2. Newborn Calf

            12.2.3.3. Others

        12.2.4. Reagents

            12.2.4.1. Albumin

            12.2.4.2. Amino Acids

            12.2.4.3. Attached Factors

            12.2.4.4. Growth Factors & Cytokines

            12.2.4.5. Protease Inhibitors

            12.2.4.6. Thrombin

            12.2.4.7. Others

    12.3. Market Value & Volume Forecast, by End-user, 2017–2031

        12.3.1. Biotechnology & Pharmaceutical Companies

        12.3.2. Academic & Research Institutes

        12.3.3. Others

    12.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis

        12.5.1. By Product Type

        12.5.2. By End-user

        12.5.3. By Country/Sub-region

13. Middle East & Africa Cell Culture Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value & Volume Forecast, by Product Type, 2017–2031

        13.2.1. Instruments

            13.2.1.1. Cell Culture Vessels (bioreactor)

            13.2.1.2. Carbon Dioxide Incubators

            13.2.1.3. Biosafety Cabinets

            13.2.1.4. Cryogenic Tanks

            13.2.1.5. Others

        13.2.2. Media Type

            13.2.2.1. Chemically-defined

            13.2.2.2. Classical Media

            13.2.2.3. Lysogeny Broth (LB)

            13.2.2.4. Protein Free

            13.2.2.5. Serum Free

            13.2.2.6. Specialty Media

        13.2.3. Sera

            13.2.3.1. Fetal Bovine

            13.2.3.2. Newborn Calf

            13.2.3.3. Others

        13.2.4. Reagents

            13.2.4.1. Albumin

            13.2.4.2. Amino Acids

            13.2.4.3. Attached Factors

            13.2.4.4. Growth Factors & Cytokines

            13.2.4.5. Protease Inhibitors

            13.2.4.6. Thrombin

            13.2.4.7. Others

    13.3. Market Value & Volume Forecast, by End-user, 2017–2031

        13.3.1. Biotechnology & Pharmaceutical Companies

        13.3.2. Academic & Research Institutes

        13.3.3. Others

    13.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis

        13.5.1. By Product Type

        13.5.2. By End-user

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix

    14.2. Market Share Analysis, by Company, 2020

    14.3. Company Profiles

        14.3.1. Thermo Fisher Scientific, Inc.

            14.3.1.1. Company Overview

            14.3.1.2. Product Portfolio

            14.3.1.3. SWOT Analysis

            14.3.1.4. Strategic Overview

        14.3.2. Merck KGaA

            14.3.2.1. Company Overview

            14.3.2.2. Product Portfolio

            14.3.2.3. SWOT Analysis

            14.3.2.4. Strategic Overview

        14.3.3. Cytiva (Danaher Corporation)

            14.3.3.1. Company Overview

            14.3.3.2. Product Portfolio

            14.3.3.3. SWOT Analysis

            14.3.3.4. Strategic Overview

        14.3.4. Becton, Dickinson and Company

            14.3.4.1. Company Overview

            14.3.4.2. Product Portfolio

            14.3.4.3. SWOT Analysis

            14.3.4.4. Strategic Overview

        14.3.5. Corning Incorporated

            14.3.5.1. Company Overview

            14.3.5.2. Product Portfolio

            14.3.5.3. SWOT Analysis

            14.3.5.4. Strategic Overview

        14.3.6. Eppendorf SE

            14.3.6.1. Company Overview

            14.3.6.2. Product Portfolio

            14.3.6.3. SWOT Analysis

            14.3.6.4. Strategic Overview

        14.3.7. HiMedia Laboratories

            14.3.7.1. Company Overview

            14.3.7.2. Product Portfolio

            14.3.7.3. SWOT Analysis

            14.3.7.4. Strategic Overview

        14.3.8. Sartorius AG

            14.3.8.1. Company Overview

            14.3.8.2. Product Portfolio

            14.3.8.3. SWOT Analysis

            14.3.8.4. Strategic Overview

        14.3.9. FUJIFILM Irvine Scientific, Inc.

            14.3.9.1. Company Overview

            14.3.9.2. Product Portfolio

            14.3.9.3. SWOT Analysis

            14.3.9.4. Strategic Overview

        14.3.10. InvivoGen

            14.3.10.1. Company Overview

            14.3.10.2. Product Portfolio

            14.3.10.3. SWOT Analysis

            14.3.10.4. Strategic Overview

        14.3.11. SeraCare (LGC Clinical Diagnostics, Inc.)

            14.3.11.1. Company Overview

            14.3.11.2. Product Portfolio

            14.3.11.3. SWOT Analysis

            14.3.11.4. Strategic Overview

        14.3.12. Miltenyi Biotec

            14.3.12.1. Company Overview

            14.3.12.2. Product Portfolio

            14.3.12.3. SWOT Analysis

            14.3.12.4. Strategic Overview

        14.3.13. STEMCELL Technologies, Inc.

            14.3.13.1. Company Overview

            14.3.13.2. Product Portfolio

            14.3.13.3. SWOT Analysis

            14.3.13.4. Strategic Overview

        14.3.14. Solida Biotech GmbH

            14.3.14.1. Company Overview

            14.3.14.2. Product Portfolio

            14.3.14.3. SWOT Analysis

            14.3.14.4. Strategic Overview

        14.3.15. Caisson Labs, Inc.

            14.3.15.1. Company Overview

            14.3.15.2. Product Portfolio

            14.3.15.3. SWOT Analysis

            14.3.15.4. Strategic Overview

        14.3.16. Cellexus

            14.3.16.1. Company Overview

            14.3.16.2. Product Portfolio

            14.3.16.3. SWOT Analysis

            14.3.16.4. Strategic Overview

        14.3.17. Pierre Guerin

            14.3.17.1. Company Overview

            14.3.17.2. Product Portfolio

            14.3.17.3. SWOT Analysis

            14.3.17.4. Strategic Overview

List of Table

Table 01: Global Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017–2031

Table 03: Global Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017–2031

Table 04: Global Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031

Table 05: Global Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031

Table 06: Global Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

Table 07: Global Cell Culture Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 08: North America Cell Culture Market Analysis Value (US$ Mn) Forecast, by Country, 2017–2031

Table 09: North America Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

Table 10: North America Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017–2031

Table 11: North America Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017–2031

Table 12: North America Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031

Table 13: North America Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031

Table 14: North America Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

Table 15: Europe Cell Culture Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 16: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

Table 17: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017–2031

Table 18: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017–2031

Table 19: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031

Table 20: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031

Table 21: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

Table 22: Asia Pacific Cell Culture Market Value (US$ Mn) Analysis & Forecast, by Country/Sub-region, 2017–2031

Table 23: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

Table 24: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017–2031

Table 25: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017–2031

Table 26: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031

Table 27: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031

Table 28: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

Table 29: Latin America Cell Culture Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 30: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

Table 31: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017–2031

Table 32: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017–2031

Table 33: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031

Table 34: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031

Table 35: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

Table 36: Middle East & Africa Cell Culture Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 37: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

Table 38: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017–2031

Table 39: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017–2031

Table 40: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031

Table 41: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031

Table 42: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Cell Culture Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Cell Culture Market Value Share, by Product, 2020

Figure 03: Global Cell Culture Market Value Share, End-user, 2020

Figure 04: Global Cell Culture Market Attractiveness Analysis, by Product, 2021–2031

Figure 05: Global Cell Culture Market Revenue (US$ Mn), by Instruments, 2017–2031

Figure 06: Global Cell Culture Market Revenue (US$ Mn), by Media, 2017–2031

Figure 07: Global Cell Culture Market Revenue (US$ Mn), by Sera, 2017–2031

Figure 08: Global Cell Culture Market Revenue (US$ Mn), by Reagents, 2017–2031

Figure 09: Global Cell Culture Market Attractiveness Analysis, by Product, 2021–2031

Figure 10: Global Cell Culture Market Attractiveness Analysis, by End-user, 2021–2031

Figure 11: Global Cell Culture Market Revenue (US$ Mn), by Biotechnology & Pharmaceutical Companies, 2017–2031

Figure 12: Global Cell Culture Market Revenue (US$ Mn), by Academic and Research Institutes, 2017–2031

Figure 13: Global Cell Culture Market Revenue (US$ Mn), by Others, 2017–2031

Figure 14: Global Cell Culture Market Attractiveness Analysis, by End-user, 2021–2031

Figure 15: Global Cell Culture Market Attractiveness Analysis, by Region, 2021–2031

Figure 16: Global Cell Culture Market Value Share Analysis, by Region, 2020 and 2031 

Figure 17: North America Cell Culture Market Analysis Value (US$ Mn) Forecast, 2017–2031

Figure 18: North America Cell Culture Market Analysis Value Share Analysis, by Country, 2020 and 2031

Figure 19: North America Cell Culture Market Analysis Attractiveness Analysis, by Country 2021–2031

Figure 20: North America Cell Culture Market Attractiveness Analysis, by Product, 2021–2031

Figure 21: North America Cell Culture Market Value Share Analysis, by Product, 2020 and 2031

Figure 22: North America Cell Culture Market Attractiveness Analysis, by End-user, 2021–2031

Figure 23: North America Cell Culture Market Value Share Analysis, by End-user, 2020 and 2031

Figure 24: Europe Cell Culture Market Analysis Value (US$ Mn) Forecast, 2017–2031

Figure 25: Europe Cell Culture Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 26: Europe Cell Culture Market Analysis Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 27: Europe Cell Culture Market Attractiveness Analysis, by Technique, 2021–2031

Figure 28: Europe Cell Culture Market Value Share Analysis, by Product, 2020 and 2031

Figure 29: Europe Cell Culture Market Attractiveness Analysis, by End-user, 2021–2031

Figure 30: Europe Cell Culture Market Value Share Analysis, by End-user, 2020 and 2031

Figure 31: Asia Pacific Cell Culture Market Value (US$ Mn) Analysis & Forecast, 2017–2031

Figure 32: Asia Pacific Cell Culture Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 33: Asia Pacific Cell Culture Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 34: Asia Pacific Cell Culture Market Attractiveness Analysis, by Technique, 2021–2031

Figure 35: Asia Pacific Cell Culture Market Value Share Analysis, by Product, 2020 and 2031

Figure 36: Asia Pacific Cell Culture Market Attractiveness Analysis, by End-user, 2021–2031

Figure 37: Asia Pacific Cell Culture Market Value Share Analysis, by End-user, 2020 and 2031

Figure 38: Latin America Cell Culture Market Value (US$ Mn) Analysis & Forecast, 2017–2031

Figure 39: Latin America Cell Culture Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 40: Latin America Cell Culture Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 41: Latin America Cell Culture Market Attractiveness Analysis, by Technique, 2021–2031

Figure 42: Latin America Cell Culture Market Value Share Analysis, by Product, 2020 and 2031

Figure 43: Latin America Cell Culture Market Attractiveness Analysis, by End-user, 2021–2031

Figure 44: Latin America Cell Culture Market Value Share Analysis, by End-user, 2020 and 2031

Figure 45: Middle East & Africa Cell Culture Market Value (US$ Mn) Analysis & Forecast, 2017–2031

Figure 46: Middle East & Africa Cell Culture Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 47: Middle East & Africa Cell Culture Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 48: Middle East & Africa Cell Culture Market Attractiveness Analysis, by Technique, 2021–2031

Figure 49: Middle East & Africa Cell Culture Market Value Share Analysis, by Product, 2020 and 2031

Figure 50: Middle East & Africa Cell Culture Market Attractiveness Analysis, by End-user, 2021–2031

Figure 51: Middle East & Africa Cell Culture Market Value Share Analysis, by End-user, 2020 and 2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

346

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved